Zoetis to Acquire Petcare Genetics Specialist Basepaws.

MANews-(C)2009-2022

US-based animal health company Zoetis Inc. (NYSE: ZTS) has agreed to acquire US-based privately held petcare genetics company Basepaws, the company said.

Basepaws provides pet owners with genetic tests, analytics and early health risk assessments that can help manage the health, wellness and quality of care for their pets.

The acquisition will advance Zoetis' portfolio in the precision animal health space and will inform and shape its future pipeline of petcare innovations.

Financial terms of the agreement are not being disclosed.

Zoetis' R and D organization has brought innovation to petcare over the last 10 years in dermatology, parasiticides and pain, and the Basepaws database will help refine and inform the company's pipeline and future targets.

Basepaws...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT